Help | RSS Feed



Biostage, Inc. (OTCMKT:BSTG) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Biostage, Inc. (OTCMKT:BSTG) seasonal charts above shows that a Buy Date of December 17 and a Sell Date of April 30 has resulted in a geometric average return of 10.03% above the benchmark rate of the S&P 500 Total Return Index over the past 7 years. This seasonal timeframe has shown positive results compared to the benchmark in 6 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 7 years by an average of 62.48% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 7 years of data is available for shares of BSTG, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Biostage Inc is a biotechnology company which is developing engineered organ implants based on novel Cellframe technology. The Cellframe technology platform is being developed to treat life-threatening conditions of the esophagus, bronchus, and trachea. Its platform technology provides surgeons a new paradigm to address life-threatening conditions of the esophagus, bronchus, and trachea due to cancer, infection, trauma or congenital abnormalities.

To download BSTG seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z